To view this email as a web page, click here.
 
FDA: Deaths linked to obesity devices
FDA is warning that 2 liquid-filled intragastric balloon systems used to treat obesity are causing deaths in some patients.
Read more
 
How FDA is accelerating generics, biosimilars to market
FDA’s new guidance on Risk Evaluation and Mitigation Strategy (REMS) requirements aims to help generic and biosimilar drugs get to market faster.
Read more
 
Top 3 new drug approvals
The top 3 new US drug approvals include the first non-opioid treatment for opioid withdrawal, a migraine prevention drug, and the first biosimilar for anemia. Here are the top 3 new drugs, approved by FDA in May.
Read more
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.